Cdn-links.lww.com



Supplemental Table 1. Patient transitions from one liver disease severity stage to next stage during follow-up (up to 8 years)NAFLD/NASHCCDCCHCCLTNAFLD/NASHx3592 (1.4%)69,924 (27.3%)332 (0.13%)307 (0.12%)CC?x730 (20.3%)*12 (0.33%)DCC??x110 (0.15%)227 (0.32%)HCC???x29 (5.0%)LT????x*N<11 (Censored due to Medicare CMS restrictions)Footnote: Not requiring at least 1-month of follow-up necessary for cost calculationsCC, compensated cirrhosis; DCC, decompensated cirrhosis; HCC, hepatocellular carcinoma; LT, liver transplant; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download